Advertisement

Topics

No serious adverse events seen with gene therapy for X-linked retinoschisis

10:30 EDT 15 Jun 2017 | Healio

Patients with X-linked retinoschisis who underwent treatment with adeno-associated virus-based gene therapy developed no treatment-related serious adverse events through 12 months, according to interim safety data from a phase 1/2 trial.Safety data for 12 of 27 patients treated with adeno-associated virus-based gene therapy (Applied Genetic Technologies Corporation) showed that the treatment is generally well tolerated through 1 year, according to a presentation by Mark E. Pennesi, MD, PhD, at the Macula Society annual meeting in Singapore.

Original Article: No serious adverse events seen with gene therapy for X-linked retinoschisis

NEXT ARTICLE

More From BioPortfolio on "No serious adverse events seen with gene therapy for X-linked retinoschisis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...